Mechanistically, the aberrant expression and activation of TAZ in pancreatic cancer cells was due to suppression of Merlin expression, which was a positive upstream regulator of the Hippo pathway, and the oncogenic function of TAZ in pancreatic cancer was mediated by the TEAD family transcription factors. This evidence concerns the gene WWTR1 and pancreatic neoplasm.